Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Benchtop DNP polarizer enabling highly sensitive hyperpolarized NMR analysis

Project description

Cost-effective, sensitive nuclear magnetic resonance could radically enhance molecular analysis

Nuclear magnetic resonance (NMR) spectroscopy is used to study molecule structure and composition. Despite being powerful tools in many fields, traditional NMR systems are expensive and complex, which limits their widespread adoption. Benchtop NMR spectrometers offer a more affordable and compact alternative, but their lower sensitivity reduces performance. To boost signal strength, the ERC-funded BenchHyp project plans to develop a breakthrough hyperpolarisation system that helps align more atomic nuclei in the same direction. The use of an innovative flow cryostat with a sliding-sample mechanism will enable continuous, reusable hyperpolarisation without waste. This advancement will make NMR more cost-effective and practical for routine applications, transforming its use in chemical analysis, pharmaceutical quality control and metabolomics.

Objective

Nuclear Magnetic Resonance (NMR) spectroscopy is a powerful analytical technique in chemistry, pharmaceuticals, and metabolomics, but requires complex and expensive infrastructure, limiting its widespread adoption. Since recently, the development of Benchtop NMR spectrometers offers a simple, compact, and low-cost alternative compared to traditional high-field systems, and their market has seen a significant growth. However, benchtop NMR faces a critical restraint which is its order of magnitude lower sensitivity. Hyperpolarization by dissolution dynamic nuclear polarization (dDNP) offers a solution by dramatically enhancing NMR signal strength but is limited to a handful of groups due to its complexity and dramatic costs, as it operates at high-fields and very low temperatures. The BenchHyp project introduces a breakthrough approach by developing a compact, reusable, and scalable hyperpolarization system compatible with benchtop NMR spectrometers. The core innovation is a flow cryostat with a sliding-sample mechanism, enabling continuous hyperpolarization without sample destruction or dilution. Unlike conventional dDNP, BenchHyp allows multiple reuses of hyperpolarized solutions, significantly reducing costs and enabling real-time, repeated measurements for applications in chemical analysis, pharmaceutical quality control, and metabolomics. This Proof of Concept will advance the technology from TRL 2 to TRL 4, focusing on prototype optimization, industrial validation, and market assessment. The project will also explore commercialization pathways, evaluating licensing, co-development with industry, or a spin-off. An IP strategy and freedom-to-operate analysis will be conducted to safeguard the innovation. BenchHyp has the potential to revolutionize benchtop NMR, bridging the gap between cutting-edge hyperpolarization and routine laboratory applications, paving the way for its widespread industrial adoption and market deployment.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-POC

See all projects funded under this call

Host institution

UNIVERSITE LYON 1 CLAUDE BERNARD
Net EU contribution
€ 150 000,00
Address
BOULEVARD DU 11 NOVEMBRE 1918 NUM43
69622 Villeurbanne Cedex
France
Region
Auvergne-Rhône-Alpes Rhône-Alpes Rhône
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)